Profil bibliographique

Akari Ozawa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
5Citations signalées
1Affiliations récentes

Les institutions déclarées

Hamamatsu University School of Medicine

Les domaines associés

Blood groups and transfusionChronic Lymphocytic Leukemia ResearchErythrocyte Function and PathophysiologyMultiple Myeloma Research and TreatmentsBlood transfusion and management

Les publications récentes

2020 article OpenAlex

A newly devised flow cytometric antibody binding assay helps evaluation of dithiothreitol treatment for the inactivation of CD38 on red blood cells

Hiroaki Furumaki, Akihiro Takeshita, Hitoshi Ohto, Chiaki Yamada et autres

BACKGROUND AND OBJECTIVES: Anti-CD38 monoclonal antibodies, including daratumumab and isatuximab, often interfere with pretransfusion testing. Dithiothreitol (DTT) treatment of red blood cells (RBCs) negates this interference. However, the optimum DTT concentration and treatment time have not been well defined. Here, we quantified …

jp (code pays fourni par la source)

3 citations Vox Sanguinis
2019 conference-abstract OpenAlex

Optimum DTT Concentration and Treatment Time for CD38 Inactivation on RBCs Analyzed By a Newly-Devised Flow Cytometric Antibody Binding Assay

Hiroaki Furumaki, Akihiro Takeshita, Chiaki Yamada, Harumi Fujihara et autres

Background: Anti-CD38 monoclonal antibodies (MoAbs), including daratumumab and isatuximab, are introduced in the treatment of multiple myeloma (MM). However, CD38 is also expressed on red blood cells (RBCs), so that free anti-CD38 MoAbs in patient sera sometimes binds to test RBCs in …

jp (code pays fourni par la source)

1 citation Blood
Accès ouvert 2019 article OpenAlex

PROSPECTIVE STUDY ON THE EXPRESSION OF IRREGULAR ERYTHROCYTE ANTIBODIES AFTER TRANSFUSION-A PILOT STUDY-

Harumi Fujihara, Keiko Ishizuka, Hiroko Watanabe, Hiroaki Furumaki et autres

不規則抗体検査は，通常赤血球製剤の輸血後には実施しないため，輸血後の各不規則抗体の真の陽性率は不明である．輸血後の不規則抗体の陽性化について多施設共同前方向性研究を企画し，今回はそのパイロット試験を実施した．

jp (code pays fourni par la source)

1 citation Japanese Journal of Transfusion and Cell Therapy
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.